论文部分内容阅读
非小细胞肺癌由于化疗敏感性低,化疗5年生存率与小细胞肺癌存在着巨大的差距。如何提高非小细胞肺癌的治疗效果被国内外医学界广泛关注。本科室于1999年1月～2000年1月对康莱特注射液对非小细胞肺癌多药耐药基因Ｐｇｐ的影响进行了临床研究,总结报告如下。1 临床资料1.1 一般
Non-small cell lung cancer has low sensitivity to chemotherapy, and there is a huge gap between 5-year survival rate of chemotherapy and small cell lung cancer. How to improve the therapeutic effect of non-small cell lung cancer has been widely concerned by the medical community at home and abroad. The clinical study on the effect of Kanglaite injection on the multidrug resistance gene Pgp in non-small cell lung cancer was conducted in the department from January 1999 to January 2000. The summary report is as follows. 1 Clinical data 1.1 General